ASCO® 2024 Highlights: Presenter Vignette – Paolo Ascierto

Dr. Paolo Ascierto

Paolo Ascierto

PA, MD

Istituto Nazionale Tumori Fondazione "G. Pascale"

Abstract# 9504

Efficacy and safety of triplet nivolumab, relatlimab, and ipilimumab (NIVO + RELA + IPI) in advanced melanoma: Results from RELATIVITY-048.